Rajiv Batra, Head of India, ASEAN, APAC, Ex of Japan/China Equity Strategy at JPMorgan expects earnings to be subdued in the second quarter but start…

With Monday’s surge, the shares of Bajaj Healthcare have turned positive for 2024.

The aim of this integration move is to consolidate all of the generics formulations business of Ipca Group USA under one single entity.

Brokerage firm Investec expects that earnings momentum, along with strong cash flow generation, will continue to support the company’s ongoing re-rating.

Ahead of the issue opening, Manba Finance has raised ₹45 crore from eight institutional investors via its anchor book.

Hind Rectifiers Share Price | The order will be executed by FY26, as per the terms and conditions outlined by Indian Railways, Hind Rectifiers said…

PSP Projects Share Price | The orders include the construction of Gold Stone Hotel and Commercial Towers at Bengaluru worth ₹389.29 crore in institutitional category…

Gold prices today: On the international front, spot gold climbed 0.2% to $2,628.28 per ounce, reaching an all-time high of $2,630.93 per ounce earlier in…

Ipca Laboratories Ltd. will hold a board meeting on September 30, 2024, to discuss the integration of its US generics formulations business.

The proxy advisory firm believes that since the listed entity is in the midst of a raging corporate battle involving the Burman family; the capital…